Ovarian Cyst Daily

ABBOTT PARK, Ill., Feb. 8 /PRNewswire-FirstCall/ — A new diagnostic tool physicians can use to monitor patients for the most common form of ovarian cancer may soon be available in the United States. Abbott’s ARCHITECT HE4 assay uses a simple blood test to help in monitoring for the recurrence or progression of epithelial ovarian cancer. [...]

Abbott Labs before the end of the year plans to debut its Architect HE4 assay, which is designed to help oncologists monitor patients with epithelial ovarian cancer, the most common form of the disease. Abbott today announced it had submitted the immunoassay for regulatory approval with FDA. The company is betting the blood-based assay will [...]

Australian comedian and actress Jean Kittson has urged Australian women to learn the symptoms of ovarian cancer because, despite popular belief, a Pap smear won’t detect it. Kittson, the ambassador for Ovarian Cancer Awareness Month, is encouraging women of all ages to read up on the symptoms in a bid to help curb the high [...]

Despite a recent consensus statement encouraging use of certain symptoms in the diagnosis of ovarian cancer, symptoms such as abdominal pain or urinary urgency are poor predictors of the disease, particularly early-stage disease, according to a study published online Jan. 28 in the Journal of the National Cancer Institute. Mary Anne Rossing, Ph.D., and colleagues [...]

Scientists in Birmingham are running one of the first UK trials of a new drug offering hope to people suffering hereditary forms of both breast and ovarian cancer. The Cancer Research UK clinical trial is open to patients who have already developed an advanced form of breast or ovarian cancer and have been diagnosed with [...]